| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0009 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.26 | 0.001 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |